Effect of Spironolactone on QRS Duration in Patients at Risk for Heart Failure (from the HOMAGE Trial).
Ferreira JP, Cleland JGF, Girerd N, Pellicori P, Hazebroek MR, Verdonschot J, Collier TJ, Petutschnigg J, Clark AL, Staessen JA, Heymans S, Rossignol P, Zannad F.
Ferreira JP, et al. Among authors: rossignol p.
Am J Cardiol. 2023 Mar 15;191:39-42. doi: 10.1016/j.amjcard.2022.12.016. Epub 2023 Jan 10.
Am J Cardiol. 2023.
PMID: 36634548
Free article.
Clinical Trial.